Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
98 hedge funds and large institutions have $10.3M invested in Vaxart in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 10 closing their positions.
1,067% more call options, than puts
Call options by funds: $35K | Put options by funds: $3K
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
7% more funds holding
Funds holding: 92 → 98 (+6)
1.99% less ownership
Funds ownership: 11.98% → 9.99% (-2%)
7% less capital invested
Capital invested by funds: $11.1M → $10.3M (-$809K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$767K |
| 2 |
Renaissance Technologies
New York
|
+$260K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$116K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$97.1K |
| 5 |
HF
HRT Financial
New York
|
+$77.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$2.27M |
| 2 |
Millennium Management
New York
|
-$411K |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$278K |
| 4 |
Squarepoint
New York
|
-$156K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$145K |
VXRT Hedge Fund Activity: Q2 2025 in Review
98 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2025, worth a combined $10.3M — down 7.3% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new VXRT positions and 10 closed out — a net gain of 7 holders — while 20 added to existing stakes and 18 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $767K. The largest seller was Sio Capital Management, exiting entirely with an estimated $2.27M sold.
- 98 institutional investors held Vaxart (VXRT) as of Q2 2025, up from 92 in Q1 2025.
- Funds reported $10.3M of Vaxart stock for Q2 2025, down 7.3% quarter-over-quarter.
- 17 funds opened new Vaxart positions in Q2 2025 and 10 closed out, a net change of +7 holders.
- The largest Vaxart buyer in Q2 2025 was Marshall Wace, an estimated $767K added.
- The largest Vaxart seller in Q2 2025 was Sio Capital Management, an estimated $2.27M sold.
Based on aggregated 13F filings for Q2 2025.